KR20130010482A - 용융-압출된 다중층 필름 - Google Patents

용융-압출된 다중층 필름 Download PDF

Info

Publication number
KR20130010482A
KR20130010482A KR1020127027983A KR20127027983A KR20130010482A KR 20130010482 A KR20130010482 A KR 20130010482A KR 1020127027983 A KR1020127027983 A KR 1020127027983A KR 20127027983 A KR20127027983 A KR 20127027983A KR 20130010482 A KR20130010482 A KR 20130010482A
Authority
KR
South Korea
Prior art keywords
active ingredient
melt
layer
film
extruded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020127027983A
Other languages
English (en)
Korean (ko)
Inventor
마크 홀
카렌 코펜스
마이클 리드
우마 슈레스타
Original Assignee
다우 글로벌 테크놀로지스 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다우 글로벌 테크놀로지스 엘엘씨 filed Critical 다우 글로벌 테크놀로지스 엘엘씨
Publication of KR20130010482A publication Critical patent/KR20130010482A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Extrusion Moulding Of Plastics Or The Like (AREA)
KR1020127027983A 2010-03-26 2011-02-25 용융-압출된 다중층 필름 Ceased KR20130010482A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31789310P 2010-03-26 2010-03-26
US61/317,893 2010-03-26
PCT/US2011/026230 WO2011119288A2 (en) 2010-03-26 2011-02-25 Multilayer melt-extruded film

Publications (1)

Publication Number Publication Date
KR20130010482A true KR20130010482A (ko) 2013-01-28

Family

ID=43901622

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127027983A Ceased KR20130010482A (ko) 2010-03-26 2011-02-25 용융-압출된 다중층 필름

Country Status (6)

Country Link
US (1) US20110236443A1 (cg-RX-API-DMAC10.html)
EP (1) EP2552402B1 (cg-RX-API-DMAC10.html)
JP (1) JP5749790B2 (cg-RX-API-DMAC10.html)
KR (1) KR20130010482A (cg-RX-API-DMAC10.html)
CN (1) CN102821754B (cg-RX-API-DMAC10.html)
WO (1) WO2011119288A2 (cg-RX-API-DMAC10.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019004642A1 (ko) * 2017-06-27 2019-01-03 (주)조안엠앤에스 애완동물용 구강용해필름
KR20210030899A (ko) * 2018-04-27 2021-03-18 프레쉬 인셋 에스.에이. 1-메틸사이클로프로펜 및 알파-사이클로덱스트린의 복합체를 포함하는 조성물 및 물품
US12653182B2 (en) 2020-02-03 2026-06-16 Fresh Inset S.A. Stable 1-methylcyclopropene compositions and uses thereof

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
CN105816434B (zh) * 2016-04-19 2019-09-17 山东新华制药股份有限公司 布洛芬颗粒及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA849081A (en) * 1967-03-02 1970-08-11 Du Pont Of Canada Limited PRODUCTION OF ETHYLENE/.alpha.-OLEFIN COPOLYMERS OF IMPROVED PHYSICAL PROPERTIES
US4645812A (en) * 1983-02-28 1987-02-24 Henkel Corporation Method of suspension polymerization of vinyl chloride
US4729190A (en) * 1983-10-27 1988-03-08 Ciba-Geigy Corporation Membrane-forming polymeric systems
US5272236A (en) * 1991-10-15 1993-12-21 The Dow Chemical Company Elastic substantially linear olefin polymers
TW207987B (cg-RX-API-DMAC10.html) 1991-03-20 1993-06-21 Hoechst Ag
ES2111065T5 (es) * 1991-04-16 2005-06-16 Nippon Shinyaku Company, Limited Procedimiento para producir una dispersion solida.
US5278272A (en) 1991-10-15 1994-01-11 The Dow Chemical Company Elastic substantialy linear olefin polymers
ID16442A (id) * 1996-01-22 1997-10-02 Dow Chemical Co Polimer etilena berat molekul ultra rendah
DE19852826A1 (de) * 1998-11-17 2000-05-18 Aventis Res & Tech Gmbh & Co Poly(alpha-1,4-D-Glucan)
US6375963B1 (en) * 1999-06-16 2002-04-23 Michael A. Repka Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof
US7666337B2 (en) * 2002-04-11 2010-02-23 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
US20040180077A1 (en) 2003-03-05 2004-09-16 Riker Donald K. Rapidly dissolving edible strips for treating obesity
US20050186257A1 (en) 2004-02-20 2005-08-25 Todd Manegold Dissolvable film and method of manufacture
CN101489756B (zh) * 2006-03-24 2013-08-07 奥克思利尤姆国际控股公司 热熔挤出层压材料的制备方法
CN101616660A (zh) * 2007-01-12 2009-12-30 莫诺索尔克斯有限公司 高剂量膜组合物及其制备方法
JP5165428B2 (ja) * 2008-03-18 2013-03-21 日生化学株式会社 積層体

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019004642A1 (ko) * 2017-06-27 2019-01-03 (주)조안엠앤에스 애완동물용 구강용해필름
KR20210030899A (ko) * 2018-04-27 2021-03-18 프레쉬 인셋 에스.에이. 1-메틸사이클로프로펜 및 알파-사이클로덱스트린의 복합체를 포함하는 조성물 및 물품
US12653182B2 (en) 2020-02-03 2026-06-16 Fresh Inset S.A. Stable 1-methylcyclopropene compositions and uses thereof

Also Published As

Publication number Publication date
JP5749790B2 (ja) 2015-07-15
EP2552402B1 (en) 2016-11-23
CN102821754B (zh) 2014-06-18
CN102821754A (zh) 2012-12-12
WO2011119288A2 (en) 2011-09-29
EP2552402A2 (en) 2013-02-06
WO2011119288A3 (en) 2012-05-24
US20110236443A1 (en) 2011-09-29
JP2013523635A (ja) 2013-06-17

Similar Documents

Publication Publication Date Title
JP5749790B2 (ja) 多層溶融押出フィルム
JP5827310B2 (ja) 溶融押出フィルム
JP4838723B2 (ja) 医薬又は化粧用薬剤を送達するための迅速分解性フイルム
ES2628883T3 (es) Procedimiento para la preparación de un laminado extruido en estado fundido en caliente
KR102272442B1 (ko) 계면활성제 또는 폴리알콜을 포함하지 않은 즉각적 습윤성의 경구용 필름 제형
JP2017537127A (ja) 線状多糖をベースとするフィルム製品
JPWO2006070578A1 (ja) 硬カプセルのバンドシール
ZA200402067B (en) Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds.
JP2009513669A (ja) 親水性ベヒクルに基づく二重制御された放出マトリクスシステム
GB2574878A (en) Oral compositions and mucoadhesive thin films formed therefrom
CN102892815B (zh) 熔体挤出的膜
JPWO2009041111A1 (ja) 経口投与剤
EP2889030A1 (en) Controlling the erosion rates of mucoadhesive devices that deliver actives and other compounds and providing increased and variable therapeutic blood levels
JP2013253038A (ja) 口腔内溶解型フィルム製剤
CN104884041B (zh) 用于治疗和食品用途的具有快速溶解时间的口服分散膜
EP4135655A1 (en) Oral thin film with smooth fused film
JP2002534373A (ja) ヒドロキシプロピルセルロースとアニオンポリマーを含有する組成物、および医薬フィルムコーティングとしてのその使用
Sabareesh et al. Nanoparticles loaded mucoadhesive buccal patches: Review
JP2024508601A (ja) 多層経口薄フィルム
CN1250205C (zh) 口服颗粒制剂
Dave et al. A review on promising novel drug delivery system-bioadhesive drug delivery system
HK40121265A (en) Poultice and method for manufacturing same
EP4483865A1 (en) Poultice and method for manufacturing same
WO2022152878A1 (de) Oraler dünnfilm mit pva-tris-pufferschicht
JP2005334122A (ja) 錠剤の被覆方法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20121025

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20160223

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20170213

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20170630

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20170213

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I